Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1613.13 Million | USD 2702.3 Million | 5.9% | 2023 |
According to Zion Market Research, the global Spinal Cord Stimulators Market was worth USD 1613.13 Million in 2023. The market is forecast to reach USD 2702.3 Million by 2032, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2024-2032.
The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Spinal Cord Stimulators Market industry over the next decade.
A Spinal Cord Stimulator (SCS) device is surgically placed under the skin and sends a mild electric current to the spinal cord. It helps in the reduction of pain because the electrical pulses modify and mask the pain signal from reaching the brain.
The spinal cord stimulator (SCS), also called the dorsal column stimulator is a neuromodulation tool that is implanted in the body to treat chronic pain. By emitting electric signals that block pain signals, the device stops the brain from being able to perceive pain. The purpose of having a stimulator is to manage the pain related to spinal cord, back, arms, and legs. Medically, it is used in treating chronic pain conditions that fail to respond to medication and other massage therapies. Thus, the SCS therapy follows neurostimulation that enables electrical impulses to relieve chronic pain in the joints.
Due to technical improvement, the emergence of legislative guidelines for SCS operations, and the quick uptake of minimally invasive therapies, SCS is drawing more attention globally. The market is booming at present and is expected to create move avenues in the forthcoming years based on high adoption of neurostimulation and a high prevalence of chronic pain in the population owing to the pursuit of sedentary lifestyle.
The rising population suffering from chronic pain, favorable reimbursement policies, and a rise in the adoption of spinal cord stimulators for the relief of pain are some of the key aspects that are boosting the growth of the global spinal cord stimulator market.
Emerging spinal cord stimulation therapy guidelines is also driving the growth of the global spinal cord stimulators market. Covid-19 impacted negatively the healthcare industry resulting in the decline of spinal cord stimulation.
However, an increase in well-established healthcare sectors and the rising awareness among patients of advanced technology for pain management are driving the growth of the market. Ongoing research and investment by the government are also contributing to the growth of the spinal cord stimulators market globally.
North America is dominating the global market owing to market expansion as a result of new government regulations and favourable health reimbursement. The market in North America is being driven by the strategic presence of major competitors in the U.S. and new product launches.
Asia Pacific accounted for a significant CAGR during the forecast period. Owing to the presence of a high geriatric population and the quick adoption of neuromodulation therapy, the market growth in manifolds in the coming years. Middle East and Africa, Latin America, and other regions make up the remainder of the world, which has enormous growth potential and is expected to become a valuable market. The expansion of the market in other parts of the world is influenced by factors such as the rising prevalence of chronic back pain and the rising demand for minimally invasive therapies.
The Spinal Cord Stimulators Market is segmented based on disease indication, product, end-user, and region. On the basis of disease indication, the Spinal Cord Stimulators Market is segmented into complex regional pain syndrome (CRPS), failed back surgery syndrome (FBSS), degenerative disc disease, and others. Based on the product, the Spinal Cord Stimulators Market is bifurcated into non-rechargeable and rechargeable. On the basis of end-user, the Spinal Cord Stimulators Market is bifurcated into ambulatory surgical centers, hospitals, and specialty clinics.
North America is expected to contribute to the maximum share in the global spinal cord stimulators market over the forecast period due to factors such as emerging guidelines by the government, favorable health reimbursements, and the adoption of advanced technologies.
The Asia Pacific is forecasted to be the fastest growing region owing to the rise in the number of patients and the rise in preference of the patients for advanced technologies & noninvasive methods for the treatment of neuropathic pain.
Report Attributes | Report Details |
---|---|
Report Name | Spinal Cord Stimulators Market |
Market Size in 2023 | USD 1613.13 Million |
Market Forecast in 2032 | USD 2702.3 Million |
Growth Rate | CAGR of 5.9% |
Number of Pages | 110 |
Key Companies Covered | Boston Scientific Corporation, Medtronic, Abbott, Nevro Corporation, Saluda Medical Pvt Ltd, Nuvectra Corporation, Neuros Medical, Stimwave LLC, NeuroSigma, Synapse Biomedical Inc., and Cook Medical. The key players are forming various strategies such as product launches, collaborations, product development |
Segments Covered | By Disease Indication, By Product, By End User and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Some of the key players in the Spinal Cord Stimulators Market are-
The key players are forming various strategies such as product launches, collaborations, product development, and partnerships to gain a competitive advantage in the market.
FrequentlyAsked Questions
Spinal Cord Stimulators Market was worth USD 1613.13 Million in 2023.
The market is forecast to reach USD 2702.3 Million by 2032, growing at a compound annual growth rate (CAGR) of 5.9% during the forecast period 2024-2032.
Some of the key factors driving the Global Spinal Cord Stimulators Market growth are rising population suffering from chronic pain, favorable reimbursement policies, and a rise in the adoption of spinal cord stimulators for the relief of pain.
North America is expected to contribute to the maximum share in the global spinal cord stimulators market over the forecast period due to factors such as the emerging guidelines by the government, favorable health reimbursements, adoption of advanced technologies.
Some of the major companies operating in the Global Spinal Cord Stimulators Market are Boston Scientific Corporation, Medtronic, Abbott, Nevro Corporation, Saluda Medical Pvt Ltd, Nuvectra Corporation, Neuros Medical, Stimwave LLC, NeuroSigma, Synapse Biomedical Inc., Cook Medical.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed